
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Description
EQT Life Science develops novel medications, devices, and tools to address people's health concerns.
Investor Profile
EQT Life Sciences has made 177 investments, with 12 in the past 12 months and 37% as lead.
Stage Focus
- Series B (31%)
- Series A (30%)
- Series C (13%)
- Series Unknown (11%)
- Series D (6%)
- Post Ipo Equity (3%)
- Series E (2%)
- Debt Financing (2%)
- Series F (1%)
- Seed (1%)
Country Focus
- United States (30%)
- The Netherlands (21%)
- Germany (9%)
- Switzerland (9%)
- Belgium (7%)
- France (6%)
- Ireland (6%)
- United Kingdom (4%)
- Spain (2%)
- Finland (2%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Medical Device
- Pharmaceutical
- Biopharma
- Health Diagnostics
- Life Science
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.